Nesrine Mejri

515 total citations
51 papers, 317 citations indexed

About

Nesrine Mejri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nesrine Mejri has authored 51 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Nesrine Mejri's work include Breast Cancer Treatment Studies (9 papers), BRCA gene mutations in cancer (5 papers) and Genetic factors in colorectal cancer (5 papers). Nesrine Mejri is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), BRCA gene mutations in cancer (5 papers) and Genetic factors in colorectal cancer (5 papers). Nesrine Mejri collaborates with scholars based in Tunisia, United States and South Africa. Nesrine Mejri's co-authors include Hamouda Boussen, Lotfi Kochbati, Sonia Abdelhak, Yosr Hamdi, Khaled Rahal, F Benna, Raoudha Doghri, Salam Labidi, Sihem Hmissa and Olfa Messaoud and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Oncology.

In The Last Decade

Nesrine Mejri

49 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nesrine Mejri Tunisia 10 126 62 54 47 42 51 317
Fadi Nasr Lebanon 11 184 1.5× 32 0.5× 67 1.2× 29 0.6× 19 0.5× 65 357
Kate A. McBride Australia 11 170 1.3× 104 1.7× 69 1.3× 48 1.0× 77 1.8× 39 453
Asfandyar Sheikh Pakistan 11 75 0.6× 143 2.3× 35 0.6× 34 0.7× 31 0.7× 25 500
Kahindo P. Muyayalo China 12 42 0.3× 87 1.4× 46 0.9× 25 0.5× 15 0.4× 22 587
Moo Hyun Lee South Korea 13 160 1.3× 119 1.9× 162 3.0× 30 0.6× 60 1.4× 27 552
Ana S. Ferrigno Mexico 9 114 0.9× 27 0.4× 37 0.7× 17 0.4× 25 0.6× 40 279
Chloe Anthias United Kingdom 12 64 0.5× 62 1.0× 31 0.6× 16 0.3× 12 0.3× 30 514
Kyle E. Freese United States 8 134 1.1× 74 1.2× 73 1.4× 24 0.5× 27 0.6× 13 420
Ido Laskov Israel 15 212 1.7× 215 3.5× 74 1.4× 17 0.4× 46 1.1× 59 652
Andrew Ip United States 8 196 1.6× 83 1.3× 60 1.1× 13 0.3× 11 0.3× 66 415

Countries citing papers authored by Nesrine Mejri

Since Specialization
Citations

This map shows the geographic impact of Nesrine Mejri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nesrine Mejri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nesrine Mejri more than expected).

Fields of papers citing papers by Nesrine Mejri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nesrine Mejri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nesrine Mejri. The network helps show where Nesrine Mejri may publish in the future.

Co-authorship network of co-authors of Nesrine Mejri

This figure shows the co-authorship network connecting the top 25 collaborators of Nesrine Mejri. A scholar is included among the top collaborators of Nesrine Mejri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nesrine Mejri. Nesrine Mejri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boussen, Hamouda, et al.. (2024). Inflammatory breast cancer: Epidemiologic data and therapeutic results. International review of cell and molecular biology. 384. 1–23. 1 indexed citations
2.
3.
Mejri, Nesrine, et al.. (2023). EP035/#866  Adjuvant treatment for luminal breast cancer of intermediate prognosis. A96.3–A97. 1 indexed citations
4.
Mejri, Nesrine, et al.. (2021). Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Supportive Care in Cancer. 30(1). 289–293. 51 indexed citations
5.
Mlika, Mona, et al.. (2021). Amenorrhea and elevated βhuman chorionic gonadotropin of unknown origin: An unexpected location of choriocarcinoma. Gynecologic Oncology Reports. 36. 100746–100746. 2 indexed citations
6.
Hamdi, Yosr, Nesrine Mejri, Hanen Bouaziz, et al.. (2021). Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized Oncology. Frontiers in Genetics. 12. 674990–674990. 1 indexed citations
7.
Hamdi, Yosr, Nesrine Mejri, Lilia Romdhane, et al.. (2021). Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia. PLoS ONE. 16(1). e0245362–e0245362. 7 indexed citations
8.
Mejri, Nesrine, et al.. (2020). 1738P COVID-19: An additional burden on caregivers of cancer patients in Tunisia. Annals of Oncology. 31. S1017–S1017. 1 indexed citations
9.
Mejri, Nesrine, et al.. (2020). Use of complementary and alternative medicine in cancer: A Tunisian single-center experience. Bulletin du Cancer. 107(2). 209–214. 12 indexed citations
10.
Mejri, Nesrine, et al.. (2020). Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study. Oncology Research and Treatment. 43(5). 204–210. 6 indexed citations
11.
Hamdi, Yosr, Houcemeddine Othman, Nesrine Mejri, et al.. (2020). Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients. Frontiers in Genetics. 11. 552971–552971. 8 indexed citations
12.
Mejri, Nesrine, et al.. (2019). EP1.01-58 Impact of Tumour Size on the Management and Outcome of Stage III Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(10). S933–S934. 1 indexed citations
13.
Labidi, Salam, et al.. (2019). Impact of patients’ death on oncologists and coping strategies: An online survey. Annals of Oncology. 30. v669–v670. 1 indexed citations
14.
Mejri, Nesrine, et al.. (2017). Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy. Clinical & Translational Oncology. 19(12). 1524–1530. 5 indexed citations
15.
Mejri, Nesrine, et al.. (2017). Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review. Cancer Biology and Medicine. 14(2). 187–187. 10 indexed citations
16.
Mejri, Nesrine, et al.. (2017). Impact of oxaliplatin on relapse in stage II and III colorectal cancer after primary therapy in Tunisian population. Annals of Oncology. 28. iii103–iii104. 1 indexed citations
17.
Nasri, Amina, Imen Kacem, Mouna Ben Djebara, et al.. (2016). Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy. Neurological Sciences. 37(10). 1723–1725. 4 indexed citations
18.
Mejri, Nesrine, et al.. (2013). Acvbp Versus Chop for Primary Large Cell Gastric Lymphoma. Annals of Oncology. 24. iv72–iv72.
19.
Mejri, Nesrine, et al.. (2012). Testicular Synovial Sarcoma: A Case Report. SHILAP Revista de lepidopterología. 6 indexed citations
20.
Doghri, Raoudha, et al.. (2012). Cotyledonoid Dissecting Leiomyoma of the Uterus: A Report of Four Cases. Journal of Gynecologic Surgery. 29(1). 23–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fadi Nasr Breakdown of academic impact, for papers by Kate A. McBride Breakdown of academic impact, for papers by Asfandyar Sheikh Breakdown of academic impact, for papers by Kahindo P. Muyayalo Breakdown of academic impact, for papers by Moo Hyun Lee Breakdown of academic impact, for papers by Ana S. Ferrigno Breakdown of academic impact, for papers by Chloe Anthias Breakdown of academic impact, for papers by Kyle E. Freese Breakdown of academic impact, for papers by Ido Laskov Breakdown of academic impact, for papers by Andrew Ip
Rankless by CCL
2026